Am J Epidemiol 2003; 157:289-297.
Copyright © 2003 by Johns
Hopkins Bloomberg School of Public Health
ORIGINAL CONTRIBUTIONS |
Efficacy of the Female Condom as a Barrier to Semen During Intercourse
1 Department of Epidemiology and International Health, School of Public Health, University of Alabama at Birmingham, Birmingham, AL.
2 Department of Pathology, School of Medicine, University of Alabama at Birmingham, Birmingham, AL.
3 Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA.
4 Department of Obstetrics and Gynecology, School of Medicine, University of Alabama at Birmingham, Birmingham, AL.
In 1996–1998, the authors measured prostate-specific antigen (PSA) in vaginal fluid to assess the frequency of female condom failure and to evaluate the association of self-reported failure with semen exposure. Women at low risk of sexually transmitted diseases (n = 210) were recruited in Birmingham, Alabama. They were trained to use the female condom, sample vaginal fluid before and after condom use, and complete forms to report problems during each use. Semen exposure was assessed by comparing pre- and postcoital PSA levels in vaginal fluid. A total of 175 women used 2,232 condoms. The rate of semen exposure ranged from 7% to 21% of condom uses, depending on the exposure criterion. Exposure was more likely (21–34%) and more intense (mean postcoital PSA, 24.7 ng/ml) if participants reported a mechanical problem versus other problems or no problems (exposure rate, 5–20% in both instances; mean postcoital PSA, 9.6 and 7.8 ng/ml, respectively). In logistic regression analyses for repeated measurements, user-reported problems accounted for less than 59% of the instances of semen exposure. The female condom prevented semen exposure in 79–93% of condom uses. Exposure was associated with user-reported problems but also occurred in their absence. Reported problems and semen exposure decreased with user experience.
contraceptive devices, female; follow-up studies; safety; sexually transmitted diseases
Abbreviations: Abbreviations: CFHC, California Family Health Council; PSA, prostate-specific antigen; STD, sexually transmitted disease.
CiteULike 
Connotea 
Del.icio.us What's this?
Related articles in Am. J. Epidemiol.:
- Partner Characteristics, Intensity of the Intercourse, and Semen Exposure During Use of the Female Condom
- M. Louise Lawson, Maurizio Macaluso, Ann Duerr, Glen Hortin, Karen R. Hammond, Richard Blackwell, Lynn Artz, and Amy Bloom
Am. J. Epidemiol. 2003 157: 282-288.[Abstract] [FREE Full Text] - Invited Commentary: Condom Effectiveness—Will Prostate-specific Antigen Shed New Light on This Perplexing Problem?
- Markus J. Steiner, Paul J. Feldblum, and Nancy Padian
Am. J. Epidemiol. 2003 157: 298-300.[Extract] [FREE Full Text] - Macaluso et al. Respond to "Condom Effectiveness and Prostate-specific Antigen"
- Maurizio Macaluso, M. Louise Lawson, Ann Duerr, and Glen Hortin
Am. J. Epidemiol. 2003 157: 301-302.[Extract] [FREE Full Text]
This article has been cited by other articles:
|
|
 |
|
  L. Warner, D. R. Newman, M. L. Kamb, M. Fishbein, J. M. Douglas Jr, J. Zenilman, L. D'Anna, G. Bolan, J. Rogers, T. Peterman, et al. Problems with Condom Use among Patients Attending Sexually Transmitted Disease Clinics: Prevalence, Predictors, and Relation to Incident Gonorrhea and Chlamydia Am. J. Epidemiol., February 1, 2008; 167(3): 341 - 349. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. B. Polis, K. Schaffer, K. Blanchard, A. Glasier, C. C. Harper, and D. A. Grimes Advance Provision of Emergency Contraception for Pregnancy Prevention: A Meta-Analysis Obstet. Gynecol., December 1, 2007; 110(6): 1379 - 1388. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Macaluso, R. Blackwell, D. J. Jamieson, A. Kulczycki, M. P. Chen, R. Akers, D.-j. Kim, and A. Duerr Efficacy of the Male Latex Condom and of the Female Polyurethane Condom as Barriers to Semen during Intercourse: A Randomized Clinical Trial Am. J. Epidemiol., July 1, 2007; 166(1): 88 - 96. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Zaviacic and R. J. Ablin THE USE OF PROSTATE-SPECIFIC ANTIGEN AS A CRITERION FOR CONDOM EFFECTIVENESS Am. J. Epidemiol., October 1, 2005; 162(7): 704 - 705. [Full Text] [PDF]
|
|
|
|
|
|
M. M. Hobbs, M. J. Steiner, P. J. Feldblum, and N. Padian HOBBS ET AL. REPLY Am. J. Epidemiol., October 1, 2005; 162(7): 706 - 706. [Full Text] [PDF]
|
|
|
|
|
|
M. Macaluso, M. L. Lawson, and D. L. Warner MACALUSO ET AL. REPLY Am. J. Epidemiol., October 1, 2005; 162(7): 705 - 705. [Full Text] [PDF]
|
|
|
|
 |
|
 A M Minnis and N S Padian Effectiveness of female controlled barrier methods in preventing sexually transmitted infections and HIV: current evidence and future research directions Sex. Transm. Inf., June 1, 2005; 81(3): 193 - 200. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Warner, M. Macaluso, H. D. Austin, D. K. Kleinbaum, L. Artz, M. E. Fleenor, I. Brill, D. R. Newman, and E. W. Hook III Application of the Case-Crossover Design to Reduce Unmeasured Confounding in Studies of Condom Effectiveness Am. J. Epidemiol., April 15, 2005; 161(8): 765 - 773. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Mann and C. S. Stine RE: "INVITED COMMENTARY: CONDOM EFFECTIVENESS--WILL PROSTATE-SPECIFIC ANTIGEN SHED NEW LIGHT ON THIS PERPLEXING PROBLEM?" Am. J. Epidemiol., July 15, 2003; 158(2): 193 - 193. [Full Text] [PDF]
|
|
|
|
|
|
M. J. Steiner, P. J. Feldblum, and N. Padian Invited Commentary: Condom Effectiveness--Will Prostate-specific Antigen Shed New Light on This Perplexing Problem? Am. J. Epidemiol., February 15, 2003; 157(4): 298 - 300. [Full Text] [PDF]
|
|
|
|
|
|
M. Macaluso, M. L. Lawson, A. Duerr, and G. Hortin Macaluso et al. Respond to "Condom Effectiveness and Prostate-specific Antigen" Am. J. Epidemiol., February 15, 2003; 157(4): 301 - 302. [Full Text] [PDF]
|
|